APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Daratumumab

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Daratumumab Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173982570323 December 2025172 pages

Choose your research edition.

Industry ResearchDaratumumab Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Daratumumab Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Daratumumab Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Daratumumab Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Daratumumab Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Daratumumab market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Daratumumab is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Daratumumab is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Daratumumab is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Daratumumab is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Daratumumab include Johnson＆Johnson. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Daratumumab market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Daratumumab and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Daratumumab sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Daratumumab market size, projected growth trends, production technologies, key applications, and end-use industries.

Daratumumab Segment by Company

Johnson＆Johnson

Daratumumab Segment by Type

100mg Injection

400mg Injection

Daratumumab Segment by Application

Multiple Myeloma

Follicular Lymphoma

Diffuse Large B Cell Lymphoma

Mantle Cell Lymphoma

Others

Daratumumab Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Daratumumab market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Daratumumab and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Daratumumab.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Daratumumab market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Daratumumab manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Daratumumab in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Daratumumab in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Daratumumab Industry Trends Table 2. Daratumumab Industry Drivers Table 3. Daratumumab Industry Opportunities and Challenges Table 4. Daratumumab Industry Restraints Table 5. Global Daratumumab Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Daratumumab Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Daratumumab Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Daratumumab Sales Market Share by Manufacturers Table 9. Global Daratumumab Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Daratumumab Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Daratumumab Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Daratumumab Manufacturers, Product Type & Application Table 13. Global Daratumumab Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Daratumumab by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 100mg Injection Table 17. Major Manufacturers of 400mg Injection Table 18. Global Daratumumab Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Daratumumab Sales by Type (2021-2026) & (k units) Table 20. Global Daratumumab Sales by Type (2027-2032) & (k units) Table 21. Global Daratumumab Sales Market Share by Type (2021-2026) Table 22. Global Daratumumab Sales Market Share by Type (2027-2032) Table 23. Global Daratumumab Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Daratumumab Revenue by Type (2021-2026) & (k units) Table 25. Global Daratumumab Revenue by Type (2027-2032) & (k units) Table 26. Global Daratumumab Revenue Market Share by Type (2021-2026) Table 27. Global Daratumumab Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Multiple Myeloma Table 29. Major Manufacturers of Follicular Lymphoma Table 30. Major Manufacturers of Diffuse Large B Cell Lymphoma Table 31. Major Manufacturers of Mantle Cell Lymphoma Table 32. Major Manufacturers of Others Table 33. Global Daratumumab Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Daratumumab Sales by Application (2021-2026) & (k units) Table 35. Global Daratumumab Sales by Application (2027-2032) & (k units) Table 36. Global Daratumumab Sales Market Share by Application (2021-2026) Table 37. Global Daratumumab Sales Market Share by Application (2027-2032) Table 38. Global Daratumumab Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Daratumumab Revenue by Application (2021-2026) & (k units) Table 40. Global Daratumumab Revenue by Application (2027-2032) & (k units) Table 41. Global Daratumumab Revenue Market Share by Application (2021-2026) Table 42. Global Daratumumab Revenue Market Share by Application (2027-2032) Table 43. Global Daratumumab Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Daratumumab Sales by Region (2021-2026) & (k units) Table 45. Global Daratumumab Sales Market Share by Region (2021-2026) Table 46. Global Daratumumab Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Daratumumab Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Daratumumab Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Daratumumab Sales by Country (2021-2026) & (k units) Table 50. North America Daratumumab Sales by Country (2027-2032) & (k units) Table 51. Europe Daratumumab Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Daratumumab Sales by Country (2021-2026) & (k units) Table 53. Europe Daratumumab Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Daratumumab Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Daratumumab Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Daratumumab Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Daratumumab Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Daratumumab Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Daratumumab Sales by Country (2027-2032) & (k units) Table 60. Global Daratumumab Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Daratumumab Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Daratumumab Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Daratumumab Revenue Market Share by Region (2021-2026) Table 64. Global Daratumumab Revenue Market Share by Region (2027-2032) Table 65. Johnson＆Johnson Company Information Table 66. Johnson＆Johnson Business Overview Table 67. Johnson＆Johnson Daratumumab Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Johnson＆Johnson Daratumumab Product Portfolio Table 69. Johnson＆Johnson Recent Development Table 70. Key Raw Materials Table 71. Raw Materials Key Suppliers Table 72. Daratumumab Distributors List Table 73. Daratumumab Customers List Table 74. Research Programs/Design for This Report Table 75. Authors List of This Report Table 76. Secondary Sources Table 77. Primary Sources List of Figures Figure 1. Daratumumab Product Image Figure 2. Global Daratumumab Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Daratumumab Market Size (2021-2032) & (US$ Million) Figure 4. Global Daratumumab Sales (2021-2032) & (k units) Figure 5. Global Daratumumab Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Daratumumab Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 100mg Injection Image Figure 9. 400mg Injection Image Figure 10. Global Daratumumab Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Daratumumab Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Daratumumab Sales Market Share by Type (2021-2032) Figure 13. Global Daratumumab Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Daratumumab Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Daratumumab Revenue Market Share by Type (2021-2032) Figure 16. Multiple Myeloma Image Figure 17. Follicular Lymphoma Image Figure 18. Diffuse Large B Cell Lymphoma Image Figure 19. Mantle Cell Lymphoma Image Figure 20. Others Image Figure 21. Global Daratumumab Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Daratumumab Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Daratumumab Sales Market Share by Application (2021-2032) Figure 24. Global Daratumumab Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Daratumumab Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Daratumumab Revenue Market Share by Application (2021-2032) Figure 27. North America Daratumumab Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Daratumumab Sales Market Share by Country (2021-2032) Figure 29. U.S. Daratumumab Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Daratumumab Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Daratumumab Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Daratumumab Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Daratumumab Sales Market Share by Country (2021-2032) Figure 34. Germany Daratumumab Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Daratumumab Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Daratumumab Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Daratumumab Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Daratumumab Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Daratumumab Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Daratumumab Sales Market Share by Country (2021-2032) Figure 41. China Daratumumab Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Daratumumab Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Daratumumab Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Daratumumab Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Daratumumab Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Daratumumab Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Daratumumab Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Daratumumab Sales Market Share by Country (2021-2032) Figure 49. Brazil Daratumumab Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Daratumumab Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Daratumumab Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Daratumumab Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Daratumumab Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Daratumumab Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Daratumumab Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Daratumumab Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Daratumumab Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Daratumumab Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Daratumumab Revenue (2021-2032) & (US$ Million) Figure 60. North America Daratumumab Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Daratumumab Revenue (2021-2032) & (US$ Million) Figure 62. Europe Daratumumab Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Daratumumab Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Daratumumab Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Daratumumab Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Daratumumab Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Daratumumab Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Daratumumab Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg Injection
  • 400mg Injection
Applications
  • Multiple Myeloma
  • Follicular Lymphoma
  • Diffuse Large B Cell Lymphoma
  • Mantle Cell Lymphoma
  • Others
Companies covered
  • Johnson＆Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Daratumumab Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Daratumumab Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Daratumumab Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Daratumumab Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Daratumumab Market Dynamics
  1. 2.1 Daratumumab Industry Trends
  2. 2.2 Daratumumab Industry Drivers
  3. 2.3 Daratumumab Industry Opportunities and Challenges
  4. 2.4 Daratumumab Industry Restraints
3 Daratumumab Market by Manufacturers
  1. 3.1 Global Daratumumab Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Daratumumab Sales by Manufacturers (2021-2026)
  3. 3.3 Global Daratumumab Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Daratumumab Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Daratumumab Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Daratumumab Manufacturers, Product Type & Application
  7. 3.7 Global Daratumumab Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Daratumumab Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Daratumumab Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Daratumumab Tier 1, Tier 2, and Tier 3
4 Daratumumab Market by Type
  1. 4.1 Daratumumab Type Introduction
  2. 4.1.1 100mg Injection
  3. 4.1.2 400mg Injection
  4. 4.2 Global Daratumumab Sales by Type
  5. 4.2.1 Global Daratumumab Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Daratumumab Sales by Type (2021-2032)
  7. 4.2.3 Global Daratumumab Sales Market Share by Type (2021-2032)
  8. 4.3 Global Daratumumab Revenue by Type
  9. 4.3.1 Global Daratumumab Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Daratumumab Revenue by Type (2021-2032)
  11. 4.3.3 Global Daratumumab Revenue Market Share by Type (2021-2032)
5 Daratumumab Market by Application
  1. 5.1 Daratumumab Application Introduction
  2. 5.1.1 Multiple Myeloma
  3. 5.1.2 Follicular Lymphoma
  4. 5.1.3 Diffuse Large B Cell Lymphoma
  5. 5.1.4 Mantle Cell Lymphoma
  6. 5.1.5 Others
  7. 5.2 Global Daratumumab Sales by Application
  8. 5.2.1 Global Daratumumab Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Daratumumab Sales by Application (2021-2032)
  10. 5.2.3 Global Daratumumab Sales Market Share by Application (2021-2032)
  11. 5.3 Global Daratumumab Revenue by Application
  12. 5.3.1 Global Daratumumab Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Daratumumab Revenue by Application (2021-2032)
  14. 5.3.3 Global Daratumumab Revenue Market Share by Application (2021-2032)
6 Global Daratumumab Sales by Region
  1. 6.1 Global Daratumumab Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Daratumumab Sales by Region (2021-2032)
  3. 6.2.1 Global Daratumumab Sales by Region (2021-2026)
  4. 6.2.2 Global Daratumumab Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Daratumumab Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Daratumumab Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Daratumumab Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Daratumumab Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Daratumumab Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Daratumumab Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Daratumumab Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Daratumumab Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Daratumumab Revenue by Region
  1. 7.1 Global Daratumumab Revenue by Region
  2. 7.1.1 Global Daratumumab Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Daratumumab Revenue by Region (2021-2026)
  4. 7.1.3 Global Daratumumab Revenue by Region (2027-2032)
  5. 7.1.4 Global Daratumumab Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Daratumumab Revenue (2021-2032)
  8. 7.2.2 North America Daratumumab Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Daratumumab Revenue (2021-2032)
  11. 7.3.2 Europe Daratumumab Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Daratumumab Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Daratumumab Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Daratumumab Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Daratumumab Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson＆Johnson
  2. 8.1.1 Johnson＆Johnson Company Information
  3. 8.1.2 Johnson＆Johnson Business Overview
  4. 8.1.3 Johnson＆Johnson Daratumumab Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Johnson＆Johnson Daratumumab Product Portfolio
  6. 8.1.5 Johnson＆Johnson Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Daratumumab Value Chain Analysis
  2. 9.1.1 Daratumumab Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Daratumumab Production Mode & Process
  6. 9.2 Daratumumab Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Daratumumab Distributors
  9. 9.2.3 Daratumumab Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst